The global market for Peptide Manufacturing and Development Services was valued at US$ 4558 million in the year 2024 and is projected to reach a revised size of US$ 7984 million by 2031, growing at a CAGR of 8.3% during the forecast period.

Peptide Manufacturing and Development Services Market

Peptide manufacturing and development services provide end-to-end CRO/CDMO capabilities, covering peptide sequence design, process development, scale-up, GMP manufacturing and quality support. Upstream inputs include natural and non-natural amino acids, high-loading resins, coupling/activation reagents, organic solvents, and PEG or lipid modification materials. Key downstream customers include global pharma companies, biotech firms, research institutes, IVD manufacturers, medical-aesthetics brands and functional food companies, with demand focused on GLP-1 APIs, multi-indication therapeutic peptides, long-acting modified peptides, vaccine and diagnostic peptides, and cosmetic or nutritional peptides. In 2024, global peptide CDMOs generally reported gross margins in the 10%–35% range, driven by customer mix, innovation share and capacity utilization. Market growth is supported by pro-innovation and rare-disease policies, supply-chain localization needs, process innovations such as automated and continuous-flow SPPS, and rising demand from GLP-1 therapies and healthy-aging trends.

At present, the peptide manufacturing and development service market is characterized by rapid expansion alongside structural differentiation. Demand continues to grow as peptide-based molecules gain prominence in innovative drug pipelines, technology cycles accelerate in metabolic and immuno-oncology fields, and consumer-facing applications such as aesthetics and functional nutrition broaden. Leading CDMOs consolidate their market position through technological depth, quality systems and global regulatory expertise, while new entrants largely compete in lower-complexity segments, resulting in scarcity of high-end capacity and intensifying competition in the lower tiers. Differences in process sophistication, automation and supply-chain resilience create an increasingly stratified competitive landscape, where capacity utilization and project conversion efficiency become key determinants of competitiveness.

Future development will be shaped by multi-dimensional advances, including continuous-flow solid-phase synthesis, greener solvent systems, intelligent process control, high-efficiency purification technologies and sequence engineering, all of which enhance manufacturability of long, hydrophobic or heavily modified peptides. With more innovative drugs advancing into multi-regional clinical development, the need for globally distributed GMP capacity, cross-border compliance support and integrated CMC capabilities will become standard expectations. Meanwhile, peptide applications are expanding from classical therapeutic roles to precision delivery systems, drug–device combinations, vaccine adjuvants, cell therapy components, as well as aesthetic and nutritional domains, driving service providers to extend upstream into early R&D and downstream into applied innovation.

Market drivers arise from policy incentives, technological breakthroughs and evolving consumer preferences. Accelerated regulatory pathways for novel and rare-disease therapies, increasing emphasis on supply-chain security and localization, and the push for compliant manufacturing encourage pharmaceutical companies to outsource more peptide programs to specialized CDMOs. Technological progress is improving cost structures and delivery efficiency, unlocking broader commercialization potential for complex peptides. On the demand side, trends such as personalized health management, weight control and healthy aging reinforce the momentum of peptide use in medical aesthetics, functional nutrition and emerging cross-sector applications.

However, the industry also faces constraints, including supply-chain volatility for certain critical raw materials and equipment, tightening environmental regulations, and increasing regulatory complexity from clinical development through commercialization. Divergent quality standards across regions add difficulty to global project execution. The intrinsic challenges of peptide process development—long optimization cycles, scale-up risks and high requirements for cross-disciplinary expertise—limit the speed at which newcomers can build competitiveness. In addition, cost pressures, pricing dynamics and the need to maintain stable, reliable delivery place higher expectations on the operational strength and sustainability of service providers.

This report aims to provide a comprehensive presentation of the global market for Peptide Manufacturing and Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Manufacturing and Development Services.

The Peptide Manufacturing and Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Manufacturing and Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, by Synthesis Technology and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide Manufacturing and Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide Manufacturing and Development Services Market Report

Report Metric	Details
Report Name	Peptide Manufacturing and Development Services Market
Accounted market size in year	US$ 4558 million
Forecasted market size in 2031	US$ 7984 million
CAGR	8.3%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	GMP Services Non-GMP Services
Segment by Synthesis Technology	SPPS LPPS Hybrid Technology
Segment by Customer	Pharma Companies Biotech Firms Academic & Research Others
Segment by Form	Peptide APIs Intermediates Modified & Conjugated Peptides Others
Segment by Application	Pharmaceutical & Biotechnology Diagnostics & IVD Aesthetics & Dermatology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	PolyPeptide, Bachem, AmbioPharm, CordenPharma, CPC Scientific, Piramal Pharma Solutions, Almac Group, Vtides Life Sciences, Aspen Holdings, Neuland Laboratories, USV, Aurigene Pharmaceutical Services, CBL, Provepharm, PeptiStar, Creative Peptides, Space Peptides, Cambrex, ScinoPharm, Chinese Peptide Company, ChengDu ShengNuo Biotec, WuXi TIDES, Genscript
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Synthesis Technology etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide Manufacturing and Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide Manufacturing and Development Services Market growing?

Ans: The Peptide Manufacturing and Development Services Market witnessing a CAGR of 8.3% during the forecast period 2026-2031.

What is the Peptide Manufacturing and Development Services Market size in 2031?

Ans: The Peptide Manufacturing and Development Services Market size in 2031 will be US$ 7984 million.

Who are the main players in the Peptide Manufacturing and Development Services Market report?

Ans: The main players in the Peptide Manufacturing and Development Services Market are PolyPeptide, Bachem, AmbioPharm, CordenPharma, CPC Scientific, Piramal Pharma Solutions, Almac Group, Vtides Life Sciences, Aspen Holdings, Neuland Laboratories, USV, Aurigene Pharmaceutical Services, CBL, Provepharm, PeptiStar, Creative Peptides, Space Peptides, Cambrex, ScinoPharm, Chinese Peptide Company, ChengDu ShengNuo Biotec, WuXi TIDES, Genscript

What are the Application segmentation covered in the Peptide Manufacturing and Development Services Market report?

Ans: The Applications covered in the Peptide Manufacturing and Development Services Market report are Pharmaceutical & Biotechnology, Diagnostics & IVD, Aesthetics & Dermatology, Others

What are the Type segmentation covered in the Peptide Manufacturing and Development Services Market report?

Ans: The Types covered in the Peptide Manufacturing and Development Services Market report are GMP Services, Non-GMP Services

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 GMP Services

1.2.3 Non-GMP Services

1.3 Market by Synthesis Technology

1.3.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Synthesis Technology: 2020 VS 2024 VS 2031

1.3.2 SPPS

1.3.3 LPPS

1.3.4 Hybrid Technology

1.4 Market by Customer

1.4.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Customer: 2020 VS 2024 VS 2031

1.4.2 Pharma Companies

1.4.3 Biotech Firms

1.4.4 Academic & Research

1.4.5 Others

1.5 Market by Form

1.5.1 Global Peptide Manufacturing and Development Services Market Size Growth Rate by Form: 2020 VS 2024 VS 2031

1.5.2 Peptide APIs

1.5.3 Intermediates

1.5.4 Modified & Conjugated Peptides

1.5.5 Others

1.6 Market by Application

1.6.1 Global Peptide Manufacturing and Development Services Market Growth by Application: 2020 VS 2024 VS 2031

1.6.2 Pharmaceutical & Biotechnology

1.6.3 Diagnostics & IVD

1.6.4 Aesthetics & Dermatology

1.6.5 Others

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Global Growth Trends

2.1 Global Peptide Manufacturing and Development Services Market Perspective (2020-2031)

2.2 Global Peptide Manufacturing and Development Services Growth Trends by Region

2.2.1 Global Peptide Manufacturing and Development Services Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Peptide Manufacturing and Development Services Historic Market Size by Region (2020-2025)

2.2.3 Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031)

2.3 Peptide Manufacturing and Development Services Market Dynamics

2.3.1 Peptide Manufacturing and Development Services Industry Trends

2.3.2 Peptide Manufacturing and Development Services Market Drivers

2.3.3 Peptide Manufacturing and Development Services Market Challenges

2.3.4 Peptide Manufacturing and Development Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide Manufacturing and Development Services Players by Revenue

3.1.1 Global Top Peptide Manufacturing and Development Services Players by Revenue (2020-2025)

3.1.2 Global Peptide Manufacturing and Development Services Revenue Market Share by Players (2020-2025)

3.2 Global Top Peptide Manufacturing and Development Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide Manufacturing and Development Services Revenue

3.4 Global Peptide Manufacturing and Development Services Market Concentration Ratio

3.4.1 Global Peptide Manufacturing and Development Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide Manufacturing and Development Services Revenue in 2024

3.5 Global Key Players of Peptide Manufacturing and Development Services Head office and Area Served

3.6 Global Key Players of Peptide Manufacturing and Development Services, Product and Application

3.7 Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Manufacturing and Development Services Breakdown Data by Type

4.1 Global Peptide Manufacturing and Development Services Historic Market Size by Type (2020-2025)

4.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031)

5 Peptide Manufacturing and Development Services Breakdown Data by Application

5.1 Global Peptide Manufacturing and Development Services Historic Market Size by Application (2020-2025)

5.2 Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Peptide Manufacturing and Development Services Market Size (2020-2031)

6.2 North America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)

6.4 North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide Manufacturing and Development Services Market Size (2020-2031)

7.2 Europe Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025)

7.4 Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Peptide Manufacturing and Development Services Market Size (2020-2031)

8.2 Asia-Pacific Peptide Manufacturing and Development Services Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025)

8.4 Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Peptide Manufacturing and Development Services Market Size (2020-2031)

9.2 Latin America Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025)

9.4 Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide Manufacturing and Development Services Market Size (2020-2031)

10.2 Middle East & Africa Peptide Manufacturing and Development Services Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025)

10.4 Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 PolyPeptide

11.1.1 PolyPeptide Company Details

11.1.2 PolyPeptide Business Overview

11.1.3 PolyPeptide Peptide Manufacturing and Development Services Introduction

11.1.4 PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.1.5 PolyPeptide Recent Development

11.2 Bachem

11.2.1 Bachem Company Details

11.2.2 Bachem Business Overview

11.2.3 Bachem Peptide Manufacturing and Development Services Introduction

11.2.4 Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.2.5 Bachem Recent Development

11.3 AmbioPharm

11.3.1 AmbioPharm Company Details

11.3.2 AmbioPharm Business Overview

11.3.3 AmbioPharm Peptide Manufacturing and Development Services Introduction

11.3.4 AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.3.5 AmbioPharm Recent Development

11.4 CordenPharma

11.4.1 CordenPharma Company Details

11.4.2 CordenPharma Business Overview

11.4.3 CordenPharma Peptide Manufacturing and Development Services Introduction

11.4.4 CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.4.5 CordenPharma Recent Development

11.5 CPC Scientific

11.5.1 CPC Scientific Company Details

11.5.2 CPC Scientific Business Overview

11.5.3 CPC Scientific Peptide Manufacturing and Development Services Introduction

11.5.4 CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.5.5 CPC Scientific Recent Development

11.6 Piramal Pharma Solutions

11.6.1 Piramal Pharma Solutions Company Details

11.6.2 Piramal Pharma Solutions Business Overview

11.6.3 Piramal Pharma Solutions Peptide Manufacturing and Development Services Introduction

11.6.4 Piramal Pharma Solutions Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.6.5 Piramal Pharma Solutions Recent Development

11.7 Almac Group

11.7.1 Almac Group Company Details

11.7.2 Almac Group Business Overview

11.7.3 Almac Group Peptide Manufacturing and Development Services Introduction

11.7.4 Almac Group Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.7.5 Almac Group Recent Development

11.8 Vtides Life Sciences

11.8.1 Vtides Life Sciences Company Details

11.8.2 Vtides Life Sciences Business Overview

11.8.3 Vtides Life Sciences Peptide Manufacturing and Development Services Introduction

11.8.4 Vtides Life Sciences Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.8.5 Vtides Life Sciences Recent Development

11.9 Aspen Holdings

11.9.1 Aspen Holdings Company Details

11.9.2 Aspen Holdings Business Overview

11.9.3 Aspen Holdings Peptide Manufacturing and Development Services Introduction

11.9.4 Aspen Holdings Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.9.5 Aspen Holdings Recent Development

11.10 Neuland Laboratories

11.10.1 Neuland Laboratories Company Details

11.10.2 Neuland Laboratories Business Overview

11.10.3 Neuland Laboratories Peptide Manufacturing and Development Services Introduction

11.10.4 Neuland Laboratories Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.10.5 Neuland Laboratories Recent Development

11.11 USV

11.11.1 USV Company Details

11.11.2 USV Business Overview

11.11.3 USV Peptide Manufacturing and Development Services Introduction

11.11.4 USV Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.11.5 USV Recent Development

11.12 Aurigene Pharmaceutical Services

11.12.1 Aurigene Pharmaceutical Services Company Details

11.12.2 Aurigene Pharmaceutical Services Business Overview

11.12.3 Aurigene Pharmaceutical Services Peptide Manufacturing and Development Services Introduction

11.12.4 Aurigene Pharmaceutical Services Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.12.5 Aurigene Pharmaceutical Services Recent Development

11.13 CBL

11.13.1 CBL Company Details

11.13.2 CBL Business Overview

11.13.3 CBL Peptide Manufacturing and Development Services Introduction

11.13.4 CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.13.5 CBL Recent Development

11.14 Provepharm

11.14.1 Provepharm Company Details

11.14.2 Provepharm Business Overview

11.14.3 Provepharm Peptide Manufacturing and Development Services Introduction

11.14.4 Provepharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.14.5 Provepharm Recent Development

11.15 PeptiStar

11.15.1 PeptiStar Company Details

11.15.2 PeptiStar Business Overview

11.15.3 PeptiStar Peptide Manufacturing and Development Services Introduction

11.15.4 PeptiStar Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.15.5 PeptiStar Recent Development

11.16 Creative Peptides

11.16.1 Creative Peptides Company Details

11.16.2 Creative Peptides Business Overview

11.16.3 Creative Peptides Peptide Manufacturing and Development Services Introduction

11.16.4 Creative Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.16.5 Creative Peptides Recent Development

11.17 Space Peptides

11.17.1 Space Peptides Company Details

11.17.2 Space Peptides Business Overview

11.17.3 Space Peptides Peptide Manufacturing and Development Services Introduction

11.17.4 Space Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.17.5 Space Peptides Recent Development

11.18 Cambrex

11.18.1 Cambrex Company Details

11.18.2 Cambrex Business Overview

11.18.3 Cambrex Peptide Manufacturing and Development Services Introduction

11.18.4 Cambrex Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.18.5 Cambrex Recent Development

11.19 ScinoPharm

11.19.1 ScinoPharm Company Details

11.19.2 ScinoPharm Business Overview

11.19.3 ScinoPharm Peptide Manufacturing and Development Services Introduction

11.19.4 ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.19.5 ScinoPharm Recent Development

11.20 Chinese Peptide Company

11.20.1 Chinese Peptide Company Company Details

11.20.2 Chinese Peptide Company Business Overview

11.20.3 Chinese Peptide Company Peptide Manufacturing and Development Services Introduction

11.20.4 Chinese Peptide Company Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.20.5 Chinese Peptide Company Recent Development

11.21 ChengDu ShengNuo Biotec

11.21.1 ChengDu ShengNuo Biotec Company Details

11.21.2 ChengDu ShengNuo Biotec Business Overview

11.21.3 ChengDu ShengNuo Biotec Peptide Manufacturing and Development Services Introduction

11.21.4 ChengDu ShengNuo Biotec Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.21.5 ChengDu ShengNuo Biotec Recent Development

11.22 WuXi TIDES

11.22.1 WuXi TIDES Company Details

11.22.2 WuXi TIDES Business Overview

11.22.3 WuXi TIDES Peptide Manufacturing and Development Services Introduction

11.22.4 WuXi TIDES Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.22.5 WuXi TIDES Recent Development

11.23 Genscript

11.23.1 Genscript Company Details

11.23.2 Genscript Business Overview

11.23.3 Genscript Peptide Manufacturing and Development Services Introduction

11.23.4 Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025)

11.23.5 Genscript Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Bachem

PolyPeptide

CordenPharma

AmbioPharm

GenScript

ScinoPharm

CBL

CPC Scientific

Piramal Pharma Solutions

Aurigene Pharmaceutical Services

Chinese Peptide Company

ChengDu ShengNuo Biotec

WuXi TIDES

Vtides Life Sciences

List of Tables

Table 1. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of GMP Services

Table 3. Key Players of Non-GMP Services

Table 4. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Synthesis Technology (US$ Million): 2020 VS 2024 VS 2031

Table 5. Key Players of SPPS

Table 6. Key Players of LPPS

Table 7. Key Players of Hybrid Technology

Table 8. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Customer (US$ Million): 2020 VS 2024 VS 2031

Table 9. Key Players of Pharma Companies

Table 10. Key Players of Biotech Firms

Table 11. Key Players of Academic & Research

Table 12. Key Players of Others

Table 13. Global Peptide Manufacturing and Development Services Market Size Growth Rate by Form (US$ Million): 2020 VS 2024 VS 2031

Table 14. Key Players of Peptide APIs

Table 15. Key Players of Intermediates

Table 16. Key Players of Modified & Conjugated Peptides

Table 17. Key Players of Others

Table 18. Global Peptide Manufacturing and Development Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Peptide Manufacturing and Development Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 20. Global Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)

Table 21. Global Peptide Manufacturing and Development Services Market Share by Region (2020-2025)

Table 22. Global Peptide Manufacturing and Development Services Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 23. Global Peptide Manufacturing and Development Services Market Share by Region (2026-2031)

Table 24. Peptide Manufacturing and Development Services Market Trends

Table 25. Peptide Manufacturing and Development Services Market Drivers

Table 26. Peptide Manufacturing and Development Services Market Challenges

Table 27. Peptide Manufacturing and Development Services Market Restraints

Table 28. Global Peptide Manufacturing and Development Services Revenue by Players (2020-2025) & (US$ Million)

Table 29. Global Peptide Manufacturing and Development Services Market Share by Players (2020-2025)

Table 30. Global Top Peptide Manufacturing and Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Manufacturing and Development Services as of 2024)

Table 31. Ranking of Global Top Peptide Manufacturing and Development Services Companies by Revenue (US$ Million) in 2024

Table 32. Global 5 Largest Players Market Share by Peptide Manufacturing and Development Services Revenue (CR5 and HHI) & (2020-2025)

Table 33. Global Key Players of Peptide Manufacturing and Development Services, Headquarters and Area Served

Table 34. Global Key Players of Peptide Manufacturing and Development Services, Product and Application

Table 35. Global Key Players of Peptide Manufacturing and Development Services, Date of Enter into This Industry

Table 36. Mergers & Acquisitions, Expansion Plans

Table 37. Global Peptide Manufacturing and Development Services Market Size by Type (2020-2025) & (US$ Million)

Table 38. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2020-2025)

Table 39. Global Peptide Manufacturing and Development Services Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 40. Global Peptide Manufacturing and Development Services Revenue Market Share by Type (2026-2031)

Table 41. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2025) & (US$ Million)

Table 42. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2020-2025)

Table 43. Global Peptide Manufacturing and Development Services Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 44. Global Peptide Manufacturing and Development Services Revenue Market Share by Application (2026-2031)

Table 45. North America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. North America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 47. North America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 48. Europe Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Europe Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 50. Europe Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 51. Asia-Pacific Peptide Manufacturing and Development Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 52. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2020-2025) & (US$ Million)

Table 53. Asia-Pacific Peptide Manufacturing and Development Services Market Size by Region (2026-2031) & (US$ Million)

Table 54. Latin America Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 55. Latin America Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 56. Latin America Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 57. Middle East & Africa Peptide Manufacturing and Development Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 58. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2020-2025) & (US$ Million)

Table 59. Middle East & Africa Peptide Manufacturing and Development Services Market Size by Country (2026-2031) & (US$ Million)

Table 60. PolyPeptide Company Details

Table 61. PolyPeptide Business Overview

Table 62. PolyPeptide Peptide Manufacturing and Development Services Product

Table 63. PolyPeptide Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 64. PolyPeptide Recent Development

Table 65. Bachem Company Details

Table 66. Bachem Business Overview

Table 67. Bachem Peptide Manufacturing and Development Services Product

Table 68. Bachem Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 69. Bachem Recent Development

Table 70. AmbioPharm Company Details

Table 71. AmbioPharm Business Overview

Table 72. AmbioPharm Peptide Manufacturing and Development Services Product

Table 73. AmbioPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 74. AmbioPharm Recent Development

Table 75. CordenPharma Company Details

Table 76. CordenPharma Business Overview

Table 77. CordenPharma Peptide Manufacturing and Development Services Product

Table 78. CordenPharma Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 79. CordenPharma Recent Development

Table 80. CPC Scientific Company Details

Table 81. CPC Scientific Business Overview

Table 82. CPC Scientific Peptide Manufacturing and Development Services Product

Table 83. CPC Scientific Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 84. CPC Scientific Recent Development

Table 85. Piramal Pharma Solutions Company Details

Table 86. Piramal Pharma Solutions Business Overview

Table 87. Piramal Pharma Solutions Peptide Manufacturing and Development Services Product

Table 88. Piramal Pharma Solutions Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 89. Piramal Pharma Solutions Recent Development

Table 90. Almac Group Company Details

Table 91. Almac Group Business Overview

Table 92. Almac Group Peptide Manufacturing and Development Services Product

Table 93. Almac Group Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 94. Almac Group Recent Development

Table 95. Vtides Life Sciences Company Details

Table 96. Vtides Life Sciences Business Overview

Table 97. Vtides Life Sciences Peptide Manufacturing and Development Services Product

Table 98. Vtides Life Sciences Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 99. Vtides Life Sciences Recent Development

Table 100. Aspen Holdings Company Details

Table 101. Aspen Holdings Business Overview

Table 102. Aspen Holdings Peptide Manufacturing and Development Services Product

Table 103. Aspen Holdings Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 104. Aspen Holdings Recent Development

Table 105. Neuland Laboratories Company Details

Table 106. Neuland Laboratories Business Overview

Table 107. Neuland Laboratories Peptide Manufacturing and Development Services Product

Table 108. Neuland Laboratories Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 109. Neuland Laboratories Recent Development

Table 110. USV Company Details

Table 111. USV Business Overview

Table 112. USV Peptide Manufacturing and Development Services Product

Table 113. USV Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 114. USV Recent Development

Table 115. Aurigene Pharmaceutical Services Company Details

Table 116. Aurigene Pharmaceutical Services Business Overview

Table 117. Aurigene Pharmaceutical Services Peptide Manufacturing and Development Services Product

Table 118. Aurigene Pharmaceutical Services Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 119. Aurigene Pharmaceutical Services Recent Development

Table 120. CBL Company Details

Table 121. CBL Business Overview

Table 122. CBL Peptide Manufacturing and Development Services Product

Table 123. CBL Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 124. CBL Recent Development

Table 125. Provepharm Company Details

Table 126. Provepharm Business Overview

Table 127. Provepharm Peptide Manufacturing and Development Services Product

Table 128. Provepharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 129. Provepharm Recent Development

Table 130. PeptiStar Company Details

Table 131. PeptiStar Business Overview

Table 132. PeptiStar Peptide Manufacturing and Development Services Product

Table 133. PeptiStar Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 134. PeptiStar Recent Development

Table 135. Creative Peptides Company Details

Table 136. Creative Peptides Business Overview

Table 137. Creative Peptides Peptide Manufacturing and Development Services Product

Table 138. Creative Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 139. Creative Peptides Recent Development

Table 140. Space Peptides Company Details

Table 141. Space Peptides Business Overview

Table 142. Space Peptides Peptide Manufacturing and Development Services Product

Table 143. Space Peptides Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 144. Space Peptides Recent Development

Table 145. Cambrex Company Details

Table 146. Cambrex Business Overview

Table 147. Cambrex Peptide Manufacturing and Development Services Product

Table 148. Cambrex Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 149. Cambrex Recent Development

Table 150. ScinoPharm Company Details

Table 151. ScinoPharm Business Overview

Table 152. ScinoPharm Peptide Manufacturing and Development Services Product

Table 153. ScinoPharm Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 154. ScinoPharm Recent Development

Table 155. Chinese Peptide Company Company Details

Table 156. Chinese Peptide Company Business Overview

Table 157. Chinese Peptide Company Peptide Manufacturing and Development Services Product

Table 158. Chinese Peptide Company Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 159. Chinese Peptide Company Recent Development

Table 160. ChengDu ShengNuo Biotec Company Details

Table 161. ChengDu ShengNuo Biotec Business Overview

Table 162. ChengDu ShengNuo Biotec Peptide Manufacturing and Development Services Product

Table 163. ChengDu ShengNuo Biotec Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 164. ChengDu ShengNuo Biotec Recent Development

Table 165. WuXi TIDES Company Details

Table 166. WuXi TIDES Business Overview

Table 167. WuXi TIDES Peptide Manufacturing and Development Services Product

Table 168. WuXi TIDES Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 169. WuXi TIDES Recent Development

Table 170. Genscript Company Details

Table 171. Genscript Business Overview

Table 172. Genscript Peptide Manufacturing and Development Services Product

Table 173. Genscript Revenue in Peptide Manufacturing and Development Services Business (2020-2025) & (US$ Million)

Table 174. Genscript Recent Development

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

Table 178. Authors List of This Report

List of Figures

Figure 1. Peptide Manufacturing and Development Services Picture

Figure 2. Global Peptide Manufacturing and Development Services Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peptide Manufacturing and Development Services Market Share by Type: 2024 VS 2031

Figure 4. GMP Services Features

Figure 5. Non-GMP Services Features

Figure 6. Global Peptide Manufacturing and Development Services Market Size Comparison by Synthesis Technology (2020-2031) & (US$ Million)

Figure 7. SPPS Features

Figure 8. LPPS Features

Figure 9. Hybrid Technology Features

Figure 10. Global Peptide Manufacturing and Development Services Market Size Comparison by Customer (2020-2031) & (US$ Million)

Figure 11. Pharma Companies Features

Figure 12. Biotech Firms Features

Figure 13. Academic & Research Features

Figure 14. Others Features

Figure 15. Global Peptide Manufacturing and Development Services Market Size Comparison by Form (2020-2031) & (US$ Million)

Figure 16. Peptide APIs Features

Figure 17. Intermediates Features

Figure 18. Modified & Conjugated Peptides Features

Figure 19. Others Features

Figure 20. Global Peptide Manufacturing and Development Services Market Size by Application (2020-2031) & (US$ Million)

Figure 21. Global Peptide Manufacturing and Development Services Market Share by Application: 2024 VS 2031

Figure 22. Pharmaceutical & Biotechnology Case Studies

Figure 23. Diagnostics & IVD Case Studies

Figure 24. Aesthetics & Dermatology Case Studies

Figure 25. Others Case Studies

Figure 26. Peptide Manufacturing and Development Services Report Years Considered

Figure 27. Global Peptide Manufacturing and Development Services Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 28. Global Peptide Manufacturing and Development Services Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 29. Global Peptide Manufacturing and Development Services Market Share by Region: 2024 VS 2031

Figure 30. Global Peptide Manufacturing and Development Services Market Share by Players in 2024

Figure 31. Global Peptide Manufacturing and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 32. The Top 10 and 5 Players Market Share by Peptide Manufacturing and Development Services Revenue in 2024

Figure 33. North America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. North America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)

Figure 35. United States Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Canada Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Europe Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Europe Peptide Manufacturing and Development Services Market Share by Country (2020-2031)

Figure 39. Germany Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. France Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. U.K. Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Italy Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Russia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Ireland Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Asia-Pacific Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Asia-Pacific Peptide Manufacturing and Development Services Market Share by Region (2020-2031)

Figure 47. China Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Japan Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. South Korea Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Southeast Asia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. India Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Australia & New Zealand Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Latin America Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Latin America Peptide Manufacturing and Development Services Market Share by Country (2020-2031)

Figure 55. Mexico Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Brazil Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Middle East & Africa Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Middle East & Africa Peptide Manufacturing and Development Services Market Share by Country (2020-2031)

Figure 59. Israel Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. Saudi Arabia Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 61. UAE Peptide Manufacturing and Development Services Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 62. PolyPeptide Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 63. Bachem Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 64. AmbioPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 65. CordenPharma Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 66. CPC Scientific Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 67. Piramal Pharma Solutions Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 68. Almac Group Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 69. Vtides Life Sciences Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 70. Aspen Holdings Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 71. Neuland Laboratories Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 72. USV Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 73. Aurigene Pharmaceutical Services Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 74. CBL Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 75. Provepharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 76. PeptiStar Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 77. Creative Peptides Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 78. Space Peptides Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 79. Cambrex Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 80. ScinoPharm Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 81. Chinese Peptide Company Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 82. ChengDu ShengNuo Biotec Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 83. WuXi TIDES Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 84. Genscript Revenue Growth Rate in Peptide Manufacturing and Development Services Business (2020-2025)

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Peptide Analysis Services Market Research Report 2025

Global Custom Peptide Synthesis Service Market Insights Forecast to 2030

Global Customized Peptide Synthesis Service Market Research Report 2024

Global Cyclic Peptide Service Market Research Report 2024

Global Modified Peptide Synthesis Services Market Research Report 2025

Global Customized Peptide Synthesis Market Insights Forecast to 2030

Global Peptide Microarray Service Market Research Report 2024

Global Peptide Conjugates Service Market Research Report 2024

Global Peptide CDMO Services Market Research Report 2025

Global Peptide Synthesis CDMO Services Market Research Report 2024

Global Peptide Synthesis Service Market Insights Forecast to 2030

Global mRNA Development and Manufacturing Services Market Research Report 2025

Global Peptide Screening Service Market Research Report 2025

Global Standard Peptide Custom Synthesis Service Market Research Report 2024

Global Peptide Synthesis Reagent Market Research Report 2024

Global Custom Peptide CDMO Services Market Research Report 2024

Global Chemical Synthesis Peptide Drugs Market Research Report 2024

Peptide Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Library Construction and Screening Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions